{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:06:55Z","timestamp":1791090415215,"version":"4.1.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Parkinson Society of Canada"},{"name":"Canadian Institutes of Health Research (CIHR)"},{"name":"Natural Sciences and Engineering Research Council of Canada (NSERC)"},{"name":"Ontario Graduate Scholarship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.neuroscience.2009.09.025","type":"journal-article","created":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T16:37:53Z","timestamp":1253896673000},"page":"1894-1906","source":"Crossref","is-referenced-by-count":53,"title":["Interferon-\u03b3 deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat"],"prefix":"10.1016","volume":"164","author":[{"given":"D.","family":"Litteljohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hayley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2009.09.025_bib1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1289\/ehp.7867","article-title":"Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotonergic mechanisms and resembling animal models of depression","volume":"113","author":"Aldridge","year":"2005","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1289\/ehp.7968","article-title":"Alterations in central nervous system serotonergic and dopaminergic synaptic activity in adulthood after prenatal or neonatal chlorpyrifos exposure","volume":"113","author":"Aldridge","year":"2005","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF03033150","article-title":"Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's disease","volume":"5","author":"Andersen","year":"2003","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/1381612053381701","article-title":"Cytokines as a precipitant of depressive illness: animal and human studies","volume":"11","author":"Anisman","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib5","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.pnpbp.2005.03.006","article-title":"Interferon-induced depression: strategies in treatment","volume":"29","author":"Asnis","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(01)00291-1","article-title":"Measuring normal and pathological anxiety-like behaviour in mice: a review","volume":"125","author":"Belzung","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.12.003","article-title":"Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system","volume":"22","author":"Betarbet","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/bies.10067","article-title":"Animal models of Parkinson's disease","volume":"24","author":"Betarbet","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib9","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00415-008-5005-2","article-title":"Genes associated with Parkinson syndrome","volume":"255","author":"Biskup","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson's disease","volume":"2","author":"Bov\u00e9","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib12","first-page":"II3","article-title":"Pathoanatomy of Parkinson's disease","volume":"247","author":"Braak","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s004010051150","article-title":"Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system","volume":"99","author":"Braak","year":"2000","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s004010000247","article-title":"Alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei","volume":"101","author":"Braak","year":"2001","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01192-5","article-title":"Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss","volume":"823","author":"Brooks","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0026-895X(25)13607-9","article-title":"Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation during acute iron poisoning","volume":"43","author":"Burkitt","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0021-9975(08)80136-3","article-title":"Selective vulnerability of hippocampal CA3 neurones after microinfusion of paraquat into the rat substantia nigra or into the ventral tegmental area","volume":"103","author":"Cal\u00f2","year":"1990","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00213-006-0547-4","article-title":"Vulnerability of long-term neurotoxicity of chlorpyrifos: effect on schedule-induced polydipsia and a delay discounting task","volume":"189","author":"Cardona","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib19","first-page":"438","article-title":"Depression and dementia in Parkinson's disease","volume":"60","author":"Chan-Palay","year":"1993","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.toxlet.2004.02.007","article-title":"Attenuation of paraquat-induced motor behavior and neurochemical disturbances by L-valine in vivo","volume":"150","author":"Chanyachukul","year":"2004","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3565(25)33623-2","article-title":"6-fluorocatecholamine as a false adrenergic neurotransmitter","volume":"225","author":"Chiueh","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2005.03.018","article-title":"Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats","volume":"20","author":"Cicchetti","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000113432","article-title":"Influence of age and gender on cytokine expression in a murine model of Parkinson's disease","volume":"14","author":"Ciesielska","year":"2007","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.55782\/ane-2003-1461","article-title":"Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease","volume":"63","author":"Ciesielska","year":"2003","journal-title":"Acta Neurobiol Exp"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/096032719201100616","article-title":"Neurotoxic effects induced by intracerebral and systemic injection of paraquat in rats","volume":"11","author":"Corasaniti","year":"1992","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/aje\/kwp006","article-title":"Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California","volume":"169","author":"Costello","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib27","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1523\/JNEUROSCI.23-10-04081.2003","article-title":"Role of calpain in MPTP-induced dopamine neuron loss and behavioural impairment in mice","volume":"23","author":"Crocker","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/ENDO:29:2:243","article-title":"Gender differences in neurological disease: role of estrogens and cytokines","volume":"29","author":"Cz\u0142onkowska","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib29","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.8456300","article-title":"Multiple defects of immune cell function in mice with disrupted interferon-gamma genes","volume":"259","author":"Dalton","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/syn.10145","article-title":"Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice","volume":"47","author":"D'Astous","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib31","doi-asserted-by":"crossref","first-page":"12760","DOI":"10.1073\/pnas.96.22.12760","article-title":"A mechanism of paraquat toxicity involving nitric oxide synthase","volume":"96","author":"Day","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does Parkinson disease pathology begin in the brain?","volume":"61","author":"Del Tredici","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10599240801986215","article-title":"Pesticide\/environmental exposures and Parkinson's disease in East Texas","volume":"13","author":"Dhillon","year":"2008","journal-title":"J Agromedicine"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1474-4422(03)00501-5","article-title":"The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?","volume":"2","author":"Di Monte","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-0082(95)00029-1","article-title":"Oxidative stress and antioxidant therapy in Parkinson's disease","volume":"48","author":"Ebadi","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/15287390490273497","article-title":"Neurologic and immunologic effects of exposure to corticosterone, chlorpyrifos, and multiple doses of tri-ortho-tolyl phosphate over a 28-day period in rats","volume":"67","author":"Ehrich","year":"2004","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib37","first-page":"719","article-title":"Developmental neurotoxicity of environmental agents in the neonate","volume":"18","author":"Eriksson","year":"1997","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib38","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1097\/00001756-200310270-00009","article-title":"COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice","volume":"14","author":"Feng","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0304-3940(02)00704-8","article-title":"Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra","volume":"329","author":"Feng","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib40","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1471-4159.2004.02399.x","article-title":"Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum","volume":"89","author":"Ferger","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib41","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/syn.20456","article-title":"Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression","volume":"61","author":"Fernagut","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","article-title":"Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra","volume":"24","author":"Ferrari","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib43","series-title":"The mouse brain in stereotaxic coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib44","first-page":"7","article-title":"Depression antedating the onset of Parkinson's disease","volume":"45","author":"Fukunishi","year":"1991","journal-title":"Jpn J Psychiatry Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib45","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1523\/JNEUROSCI.23-15-06181.2003","article-title":"Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons","volume":"23","author":"Gao","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib46","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1096\/fj.03-0109fje","article-title":"Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease","volume":"17","author":"Gao","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0047-6374(01)00370-0","article-title":"Neuropharmacology of depression in aging and age-related diseases","volume":"1","author":"Gareri","year":"2002","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib49","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0149-7634(00)00028-2","article-title":"The role of the locus coeruleus in the development of Parkinson's disease","volume":"24","author":"Gesi","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib50","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mds.870120607","article-title":"Symptoms and duration of the prodromal phase in Parkinson's disease","volume":"12","author":"Gonera","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib51","first-page":"208","article-title":"Level of interferon-gamma, tumor necrosis factor alpha, and antibodies to them in blood serum from Parkinson disease patients","volume":"49","author":"Gribova","year":"2003","journal-title":"Biomed Khim"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","article-title":"Microglia as a source and target of cytokines","volume":"40","author":"Hanisch","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0006-8993(00)03262-5","article-title":"Central monoamine activity in genetically distinct strains of mice following a psychogenic stressor: effects of predator exposure","volume":"892","author":"Hayley","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib54","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1523\/JNEUROSCI.19-13-05654.1999","article-title":"Sensitization effects of Tumor Necrosis Factor-a: neuroendocrine, central monoamine and behavioral variations","volume":"19","author":"Hayley","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib55","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/toxsci\/kfn046","article-title":"Neurotoxicological evaluation of long-term lanthanum chloride exposure in rats","volume":"103","author":"He","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib56","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib57","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/ana.410440717","article-title":"Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?","volume":"44","author":"Hirsch","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib58","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.parkreldis.2004.10.013","article-title":"Neuroinflammatory processes in Parkinson's disease","volume":"11","author":"Hirsch","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib59","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","article-title":"Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats","volume":"84","author":"H\u00f6glinger","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib60","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","article-title":"FcepsilonRII\/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells","volume":"19","author":"Hunot","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib61","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1073\/pnas.0307453101","article-title":"JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease","volume":"101","author":"Hunot","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib62","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib63","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/15287390306358","article-title":"Immune alterations in mice exposed to the herbicide simazine","volume":"66","author":"Kim","year":"2003","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib64","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0887-2333(02)00047-4","article-title":"The immunomodulatory effects of the herbicide simazine on murine macrophage functions in vitro","volume":"16","author":"Kim","year":"2002","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib65","first-page":"27","article-title":"When does Parkinson's disease begin?","volume":"42","author":"Koller","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib66","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-5-8","article-title":"Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease","volume":"5","author":"Koprich","year":"2008","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib67","doi-asserted-by":"crossref","first-page":"II1","DOI":"10.1007\/s00415-002-1201-7","article-title":"Free radicals in Parkinson's disease","volume":"249","author":"Koutsilieri","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib68","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1353-8020(02)00021-4","article-title":"Degeneration of neuronal cells due to oxidative stress\u2014microglial contribution","volume":"8","author":"Koutsilieri","year":"2002","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib69","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1006\/brbi.1998.0546","article-title":"The influence of a targeted deletion of the IFNgamma gene on emotional behaviors","volume":"12","author":"Kustova","year":"1998","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib70","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.brainres.2007.04.018","article-title":"Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats","volume":"1155","author":"Kuter","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib71","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1289\/ehp.7571","article-title":"Early environmental origins of neurodegenerative disease in later life","volume":"113","author":"Landrigan","year":"2005","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib72","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/mds.10387","article-title":"Higher incidence of depression preceding the onset of Parkinson's disease: a register study","volume":"18","author":"Leentjens","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-1331.2008.02058.x","article-title":"Depressive symptoms in Parkinson's disease","volume":"15","author":"Lemke","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib74","first-page":"1357","article-title":"Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL\/6 mice","volume":"118","author":"Li","year":"2005","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1016\/j.neuroscience.2009.09.025_bib75","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-079X.2007.00510.x","article-title":"Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats","volume":"44","author":"Lin","year":"2008","journal-title":"J Pineal Res"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib76","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.48.6.1583","article-title":"Environmental risk factors and Parkinson's disease: a case-control study in Taiwan","volume":"48","author":"Liou","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib77","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1460-9568.2008.06371.x","article-title":"Cyclooxygenase-2 deficiency modifies the neurochemical effects, motor impairment and co-morbid anxiety provoked by paraquat administration in mice","volume":"28","author":"Litteljohn","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib78","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein","volume":"277","author":"Manning-Bog","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib81","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/mds.21023","article-title":"Validity of the 30-item geriatric depression scale in patients with Parkinson's disease","volume":"21","author":"McDonald","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib82","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-3223(03)00530-4","article-title":"Prevalence, etiology, and treatment of depression in Parkinson's disease","volume":"54","author":"McDonald","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib83","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/1097-4679(199403)50:2<286::AID-JCLP2270500223>3.0.CO;2-P","article-title":"Psychological effects of organophosphate pesticides: a review and call for research by psychologists","volume":"50","author":"Mearns","year":"1994","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib84","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/toxsci\/kfl046","article-title":"The common insecticides cyfluthrin and chlorpyrifos alter the expression of a subset of genes with diverse functions in primary human astrocytes","volume":"93","author":"Mense","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib85","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.1998.tb08230.x","article-title":"The impact of gender and estrogen on striatal dopamine neurotoxicity","volume":"844","author":"Miller","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib86","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11064-008-9656-2","article-title":"Oxidative and inflammatory pathways in Parkinson's disease","volume":"34","author":"Miller","year":"2009","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib87","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","article-title":"p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain","volume":"414","author":"Mogi","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2006.10.023","article-title":"The microglial gene regulatory network activated by interferon-gamma","volume":"183","author":"Moran","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib89","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/toxsci\/60.2.315","article-title":"Neurotoxicological outcomes of perinatal heptachlor exposure in the rat","volume":"60","author":"Moser","year":"2001","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib90","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","article-title":"Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons","volume":"27","author":"Mount","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib91","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson's disease: role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib92","doi-asserted-by":"crossref","first-page":"18053","DOI":"10.1073\/pnas.0809479105","article-title":"Brain mast cells link the immune system to anxiety-like behavior","volume":"105","author":"Nautiyal","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib93","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/138920008785821738","article-title":"Chronic immune stimulation correlates with reduced phenylalanine turnover","volume":"9","author":"Neurauter","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib94","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1468-1331.2004.00781.x","article-title":"Psychiatric comorbidity in a population of Parkinson's disease patients","volume":"11","author":"Nuti","year":"2004","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib95","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1523\/JNEUROSCI.5032-08.2009","article-title":"Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin","volume":"29","author":"O'Connor","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib96","first-page":"435","article-title":"A simple quantitative bradykinesia test in MPTP-treated mice","volume":"50","author":"Ogawa","year":"1985","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"6","key":"10.1016\/j.neuroscience.2009.09.025_bib97","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jnr.20599","article-title":"Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase-2 via CD 40: relevance to Parkinson's disease","volume":"81","author":"Okuno","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib98","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/mds.21675","article-title":"The pathogenesis of cell death in Parkinson's disease","volume":"22","author":"Olanow","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib99","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2008.07.019","article-title":"Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice","volume":"296","author":"Ookubo","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib100","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.neuroscience.2006.05.039","article-title":"Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease","volume":"141","author":"Ossowska","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib101","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1460-9568.2005.04301.x","article-title":"A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?","volume":"22","author":"Ossowska","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib102","doi-asserted-by":"crossref","first-page":"32626","DOI":"10.1074\/jbc.M404596200","article-title":"The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway","volume":"279","author":"Peng","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib103","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.expneurol.2008.11.003","article-title":"Toxicokinetics and toxicodynamics of paraquat accumulation in mouse brain","volume":"215","author":"Prasad","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib105","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2006.10.008","article-title":"Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration","volume":"25","author":"Purisai","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib106","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v66n0106","article-title":"Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction","volume":"66","author":"Raison","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib107","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/01.wnl.0000268695.63392.10","article-title":"The impact of depressive symptoms in early Parkinson disease","volume":"69","author":"Ravina","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib108","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.expneurol.2007.07.022","article-title":"Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats","volume":"208","author":"Rojo","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","article-title":"A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death","volume":"137","author":"Saijo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.103.049700","article-title":"Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration","volume":"306","author":"Salzberg-Brenhouse","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib111","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ntt.2003.10.008","article-title":"Long-term functional neurotoxicity of paraoxon and chlorpyrifos: behavioural and pharmacological evidence","volume":"26","author":"S\u00e1nchez-Santed","year":"2004","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib112","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/mds.21429","article-title":"Rate of clinical progression in Parkinson's disease","volume":"22","author":"Schrag","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib113","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1001958023096","article-title":"MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences","volume":"30","author":"Sedelis","year":"2000","journal-title":"Behav Genet"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib114","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-4347(00)80768-9","article-title":"High-performance liquid chromatography of biogenic amines and metabolites in brain, cerebrospinal fluid, urine and plasma","volume":"377","author":"Seegal","year":"1986","journal-title":"J Chromatogr"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pbb.2006.02.013","article-title":"The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice","volume":"83","author":"Shepherd","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib116","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5","article-title":"Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study","volume":"15","author":"Shiba","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib117","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1046\/j.1471-4159.2003.01929.x","article-title":"Lipopolysaccharide-induced dopaminergic cell death in rat midbrain slice cultures: role of inducible nitric oxide synthase and protection by indomethacin","volume":"86","author":"Shibata","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib118","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2006.07.058","article-title":"Exposure to predator odor stress increases efflux of frontal cortex acetylcholine and monoamines in mice: comparisons with immobilization stress and reversal by chlordiazepoxide","volume":"1114","author":"Smith","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib119","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","article-title":"Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease","volume":"16","author":"Sriram","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib120","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1096\/fj.05-5106com","article-title":"Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha","volume":"20","author":"Sriram","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention","volume":"208","author":"Tansey","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib122","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/brain\/109.2.279","article-title":"Parkinson's disease and depression","volume":"109","author":"Taylor","year":"1986","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib123","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","article-title":"Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease","volume":"39","author":"Teismann","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib124","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib125","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1460-9568.2003.02781.x","article-title":"Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype","volume":"18","author":"Thiruchelvam","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib126","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(01)02597-2","article-title":"Pesticides directly accelerate the rate of alpha synuclein fibril formation: a possible factor in Parkinson's disease","volume":"500","author":"Uversky","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib127","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson's disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib128","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.yfrne.2008.04.001","article-title":"Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases","volume":"29","author":"Vegeto","year":"2008","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib129","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","article-title":"Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease","volume":"3","author":"Vijitruth","year":"2006","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib130","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1212\/01.wnl.0000279519.99344.ad","article-title":"Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease","volume":"69","author":"Wahner","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib131","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1096\/fj.04-2457fje","article-title":"MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib132","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/096032719601500706","article-title":"No changes in behaviour, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rats","volume":"15","author":"Widdowson","year":"1996","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib133","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","article-title":"Are men at greater risk for Parkinson's disease than women?","volume":"75","author":"Wooten","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib134","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib135","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib136","first-page":"2900","article-title":"Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice","volume":"16","author":"Yang","year":"2007","journal-title":"Mol Genet"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib137","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib138","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1096\/fj.06-6006com","article-title":"3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro","volume":"20","author":"Zhang","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2009.09.025_bib139","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1096\/fj.04-1586fje","article-title":"3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452209015000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452209015000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T10:30:30Z","timestamp":1739356230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452209015000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":139,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0306452209015000"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2009.09.025","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}